City

Riyadh (1)

Stanford (1)

Condition

Hodgkin Lymphoma (Category) (2)

Classical Hodgkin Lymphoma (1)

Hodgkin Disease (1)

Hodgkin Lymphoma (1)

Lymphoma (1)

Nodular Lymphocyte Predominant Hodgkin Lymphoma (1)

Overall Status

Completed (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

King Abdullah International Medical Research Center (1)

Ranjana Advani (1)

Collaborator

Genentech, Inc. (1)

Intervention

abvd (1)

adriamycin (1)

brentuximab vedotin (1)

cyclophosphamide (1)

dacarbazine (1)

rituximab (1)

vinblastine (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

hodgkin lymphoma (category)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Classical Hodgkin Lymphoma, Hodgkin Lymphoma (Category), Hodgkin Disease Trial in Riyadh (Adriamycin, Cyclophosphamide,

Unknown status

Classical Hodgkin Lymphoma
+3 more

Adriamycin
+5 more

Riyadh, Saudi Arabia

King Abdulaziz Medical City, Ministry of National Guard

Nov 14, 2019

Lymphoma, Hodgkin Lymphoma (Category), Nodular Lymphocyte Predominant Hodgkin Lymphoma Trial in Stanford (Rituximab)

Completed

Has Results

Lymphoma
+2 more

Rituximab

Stanford, California
+1 more

Mar 8, 2017